NRX Pharmaceuticals Growth Metrics (2024-2025) | NRXP

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 100.37%-8.09%236.08%254.86%
Assets (QoQ) (Quarter) 38.97%-15.24%-18.18%107.89%-36.26%209.96%-13.60%
Cash & Equivalents Growth (1y) (Quarter) 320.62%52.63%350.00%440.33%
Cash & Equivalents (QoQ) (Quarter) 44.05%-15.79%-9.81%284.48%-47.73%148.28%8.29%
Cash from Operations Growth (1y) (Quarter) 5.20%-57.22%-25.41%-76.93%
Cash from Operations (QoQ) (Quarter) 30.21%9.99%9.02%-65.87%-15.75%28.20%-28.35%
EBITDA Margin (QoQ) (Quarter) 155,759.00
EBIT Growth (1y) (Quarter) 35.86%47.09%-33.16%-90.13%
EBIT Margin (QoQ) (Quarter) 119,241.00
EBIT (QoQ) (Quarter) -17.54%57.13%19.52%-58.18%3.04%-7.88%-14.91%
EBT Growth (1y) (Quarter) 38.03%47.07%-33.36%-117.92%
EBT Margin (QoQ) (Quarter) 112,373.00
EBT (QoQ) (Quarter) -13.58%57.18%19.50%-58.28%2.99%-7.89%-31.55%
Enterprise Value Growth (1y) (Quarter) -320.62%-52.63%-350.00%-440.33%
Enterprise Value (QoQ) (Quarter) -44.05%15.79%9.81%-284.48%47.73%-148.28%-8.29%
EPS (Basic) Growth (1y) (Quarter) 45.65%-30.67%-80.00%125.97%
EPS (Basic) (QoQ) (Quarter) -1.35%80.00%-413.33%47.77%-143.68%72.45%174.07%
FCF Margin (QoQ) (Quarter) 81,742.00
Free Cash Flow Growth (1y) (Quarter) 5.20%-57.22%-25.41%-76.93%
Free Cash Flow (QoQ) (Quarter) 30.21%9.99%9.02%-65.87%-15.75%28.20%-28.35%
Gross Margin (QoQ) (Quarter) -142.00
Gross Profit (QoQ) (Quarter) 296.55%
Net Cash Flow Growth (1y) (Quarter) 225.31%-555.61%2,811.90%402.46%
Net Cash Flow (QoQ) (Quarter) 117.67%-143.52%19.44%2,122.17%-164.26%359.06%-91.02%
Net Income Growth (1y) (Quarter) 38.03%47.07%-33.36%-117.92%
Net Income (QoQ) (Quarter) -13.58%57.18%19.50%-58.28%2.99%-7.89%-31.55%
Net Income towards Common Stockholders Growth (1y) (Quarter) 38.03%47.07%-33.36%-117.92%
Net Income towards Common Stockholders (QoQ) (Quarter) -13.58%57.18%19.50%-58.28%2.99%-7.89%-31.55%
Net Margin (QoQ) (Quarter) 112,373.00
Operating Income Growth (1y) (Quarter) 35.86%47.09%-33.16%-90.13%
Operating Income (QoQ) (Quarter) -17.54%57.13%19.52%-58.18%3.04%-7.88%-14.91%
Operating Margin (QoQ) (Quarter) 119,241.00
Profit After Tax Growth (1y) (Quarter) 15.56%-122.63%-262.91%103.97%
Profit After Tax (QoQ) (Quarter) -20.97%79.45%-459.33%39.28%-218.96%66.50%106.11%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 530.00%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -8.70%
Return on Assets Growth (1y) (Quarter) 340.00
Return on Assets (QoQ) (Quarter) 170.0081.0068.0021.00
Return on Capital Employed Growth (1y) (Quarter) 7.00
Return on Capital Employed (QoQ) (Quarter) -44.00-22.008.0065.00
Return on Equity Growth (1y) (Quarter) -8.00
Return on Equity (QoQ) (Quarter) -21.00-25.003.0035.00
Return on Sales Growth (1y) (Quarter) -8663.00
Return on Sales (QoQ) (Quarter) 1,124.00
Revenue (QoQ) (Quarter) 306.20%
Share-based Compensation Growth (1y) (Quarter) -95.04%-30.93%-29.90%-39.07%
Share-based Compensation (QoQ) (Quarter) -59.92%0.00%-411.34%103.97%458.33%1.49%-717.65%
Shareholder's Equity Growth (1y) (Quarter) -66.97%-93.65%-36.83%31.37%
Shareholder's Equity (QoQ) (Quarter) -22.05%-2.34%-23.38%-8.35%-41.55%27.68%38.12%
Total Debt Growth (1y) (Quarter) 37,792.31%1,624.92%-92.01%
Total Debt (QoQ) (Quarter) 3,526.92%101.70%-83.18%2,978.75%65.10%-99.07%